Leveraging the attributes of biologics and small molecules, and releasing the bottlenecks: a new wave of revolution in drug development.

作者: Charles Oo , Suraj S. Kalbag

DOI: 10.1586/17512433.2016.1160778

关键词:

摘要:

参考文章(17)
Kevin Brady, Rob Webster, Disposition of biologics. Advances in pharmacology (San Diego). ,vol. 63, pp. 257- 277 ,(2012) , 10.1016/B978-0-12-398339-8.00007-0
W Wang, EQ Wang, JP Balthasar, Monoclonal Antibody Pharmacokinetics and Pharmacodynamics Clinical Pharmacology & Therapeutics. ,vol. 84, pp. 548- 558 ,(2008) , 10.1038/CLPT.2008.170
Greg Koski, Mary F. Tobin, Matthew Whalen, The synergy of the whole: building a global system for clinical trials to accelerate medicines development. Clinical Therapeutics. ,vol. 36, pp. 1356- 1370 ,(2014) , 10.1016/J.CLINTHERA.2014.09.006
Alison J. Smith, New Horizons in Therapeutic Antibody Discovery Journal of Biomolecular Screening. ,vol. 20, pp. 437- 453 ,(2015) , 10.1177/1087057114562544
Tracy L. Nero, Craig J. Morton, Jessica K. Holien, Jerome Wielens, Michael W. Parker, Oncogenic protein interfaces: small molecules, big challenges Nature Reviews Cancer. ,vol. 14, pp. 248- 262 ,(2014) , 10.1038/NRC3690
Cui-Tao Lu, Ying-Zheng Zhao, Ho Lun Wong, Jun Cai, Lei Peng, Xin-Qiao Tian, Current approaches to enhance CNS delivery of drugs across the brain barriers. International Journal of Nanomedicine. ,vol. 9, pp. 2241- 2257 ,(2014) , 10.2147/IJN.S61288
Sean Ekins, Chris L. Waller, Mary P. Bradley, Alex M. Clark, Antony J. Williams, Four disruptive strategies for removing drug discovery bottlenecks. Drug Discovery Today. ,vol. 18, pp. 265- 271 ,(2013) , 10.1016/J.DRUDIS.2012.10.007
Seung Woo Chung, Taslim A. Hil-lal, Youngro Byun, Strategies for non-invasive delivery of biologics. Journal of Drug Targeting. ,vol. 20, pp. 481- 501 ,(2012) , 10.3109/1061186X.2012.693499